137 related articles for article (PubMed ID: 7666676)
1. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
[TBL] [Abstract][Full Text] [Related]
2. [Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
Poncet MF; Tavernier G; Damase-Michel C; Tran MA; Berlan M; Montastruc JL; Montastruc P
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1239-41. PubMed ID: 1659347
[TBL] [Abstract][Full Text] [Related]
3. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
4. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
Moreau P; de Champlain J; Yamaguchi N
J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
[TBL] [Abstract][Full Text] [Related]
5. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
6. Regulation of alpha 2-adrenoceptor density in normotensive and hypertensive man.
Fritschka E; Kribben A; Hoyer J; Rothschild M; Thiede HM; Distler A; Philipp T
J Hypertens Suppl; 1987 Dec; 5(5):S349-52. PubMed ID: 2832574
[TBL] [Abstract][Full Text] [Related]
7. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Donoso MV; Steiner M; Huidobro-Toro JP
J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
[TBL] [Abstract][Full Text] [Related]
8. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
Pernow J; Lundberg JM; Kaijser L
J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
[TBL] [Abstract][Full Text] [Related]
9. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
[TBL] [Abstract][Full Text] [Related]
10. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
Chang PC; Kriek E; van Brummelen P
J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
[TBL] [Abstract][Full Text] [Related]
12. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
13. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
Eisenhut S; Rascher W; Lang RE
Monatsschr Kinderheilkd; 1990 Sep; 138(9):631-4. PubMed ID: 2233767
[TBL] [Abstract][Full Text] [Related]
14. Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the kidney of the rat.
Pernow J; Thorén P; Millberg BI; Lundberg JM
Acta Physiol Scand; 1988 Sep; 134(1):53-9. PubMed ID: 3239423
[TBL] [Abstract][Full Text] [Related]
15. [Changes of plasma level of neuropeptide Y in patients with pregnancy induced hypertension].
Jin L; Wang C
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):206-8. PubMed ID: 11783361
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
[TBL] [Abstract][Full Text] [Related]
17. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
18. [Effect of neuropeptide Y and neurotensin on diurnal rhythm of blood pressure and target organ damage for essential hypertension].
Guo XW; Wang XL; Gao ZL
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Nov; 33(11):1006-9. PubMed ID: 16563248
[TBL] [Abstract][Full Text] [Related]
19. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
DiBona GF; Sawin LL
J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
